Aksjonæroppdatering | Immuvera

Aksjonæroppdatering Immuvera – fremdrift og emisjonsprosess

Aksjonæroppdatering Immuvera – fremdrift og emisjonsprosess

Contact us

Immuvera Therapeutics

Gaustadalléen 21

0349 Oslo

Norway

Email

jorund.sollid@immuvera.com

Phone

+47 93 42 35 39

Our Solution

Market Opportunity

About us

Comparative Oncology

Board of Directors

Quick Links

Immuvera Therapeutics is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Immuvera Therapeutics Copyright 2025 © All Right Reserved.

Immuvera Therapeutics is a registered company in Norway (Org.nr. 924 846 208).

Immuvera Therapeutics

Gaustadalléen 21

0349 Oslo

Norway

Email

jorund.sollid@immuvera.com

Phone

+47 93 42 35 39

Our Solution

Market Opportunity

About us

Comparative Oncology

Board of Directors

Quick Links

Immuvera Therapeutics is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Immuvera Therapeutics Copyright 2025 © All Right Reserved.

Immuvera Therapeutics is a registered company in Norway (Org.nr. 924 846 208).

Immuvera Therapeutics

Gaustadalléen 21

0349 Oslo

Norway

Email

jorund.sollid@immuvera.com

Phone

+47 93 42 35 39

Our Solution

Market Opportunity

About us

Comparative Oncology

Board of Directors

Quick Links

Immuvera Therapeutics is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Immuvera Therapeutics Copyright 2025 © All Right Reserved.

Immuvera Therapeutics is a registered company in Norway (Org.nr. 924 846 208).